All capabilities "in house" to launch in the market
We'll help you every step of the launch :
• Obtaining marketing authorisation (regulatory)
• Market analysis
• Defining the marketing strategy
• Early access programs
• Obtaining pricing and reimbursement
Our "in house" capabilities to support your drug on the market
• Distribution
• Strong service model (iQone for You)
• Sales & Marketing
• Medical Affairs
• Pharmacovigilance / Quality
10 years of expertise on the Swiss and European markets
• The management team has over 150+ years of pharma expertise gained in the big pharma
• The board is composed of successful pharmaceutical leaders
• Medical expertise
• iQone is the number 3 pharmaceutical player in Swiss biosimilars (Source : IQVIA SDU Volume Biosimilars 2023)
Focus on Biologics & Rare Diseases
• Large portfolio of biosimilars
• Inflammation & Immunology
• Oncology & Haematology
• Ophthalmology
• Dermatology
• Endocrinology
Our current partners
Celltrion Healthcare
Our main partner is currently Celltrion Healthcare, a global pharmaceutical company committed to delivering more affordable, advanced therapeutics to patients. Celltrion conducts worldwide marketing, sales and distribution of biologics through an extensive network. Its products are manufactured at state-of-the-art mammalian cell culture facilities that are designed and built to comply with the US FDA’s cGMP and the EMA’s GMP standards.
We work closely with Celltrion to bring advanced therapeutic solutions to healthcare professionals and, ultimately, their patients.
USV Private Limited
In 2020, our network of partners expanded when we entered into a collaboration with USV Private Limited, a leading Indian healthcare company. USV possesses a large portfolio of molecules and is a recognized specialist in the research, development and manufacture of pharmaceutical products. It strives to create and maintain a work environment that values people, encourages learning, nurtures original thinking and leads to collective achievement.
USV shares our focus on excellence, and we work together to provide therapeutic advances to healthcare professionals in Switzerland.
Hansa Biopharma
From the beginning of 2023, iQone Healthcare became the registered distributor for the newly approved Idefirix® (imlifidase) in Switzerland.
Celltrion Healthcare
Our main partner is currently Celltrion Healthcare, a global pharmaceutical company committed to delivering more affordable, advanced therapeutics to patients. Celltrion conducts worldwide marketing, sales and distribution of biologics through an extensive network. Its products are manufactured at state-of-the-art mammalian cell culture facilities that are designed and built to comply with the US FDA’s cGMP and the EMA’s GMP standards.
We work closely with Celltrion to bring advanced therapeutic solutions to healthcare professionals and, ultimately, their patients.
Celltrion Healthcare
USV
In 2020, our network of partners expanded with the start of our cooperation with USV Private Limited, a leading Indian healthcare company. Possessing a large portfolio of varied molecules, USV is a recognized specialist in the research, development and manufacture of pharmaceutical products. Always striving to provide added value to their customers and partners by being innovative, focused, and specialized, USV seeks to create and maintain a work environment that values people, encourages learning, nurtures inventions and leads to collective achievement. Sharing these values of excellence, we work together to provide therapeutic advances to healthcare professionals.